Premium
Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation
Author(s) -
Dadmarz R.,
Cawley J. C.
Publication year - 1988
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1988.tb04203.x
Subject(s) - antigen , cd23 , monoclonal antibody , immunology , biology , cell , cancer research , antibody , biochemistry , immunoglobulin e
Summary The relationship between α‐interferon receptor (αIFNR) numbers, B‐cell‐antigen expression and clinical stage was determined in 35 cases of typical chronic lymphocytic leukaemia (CLL). αIFNR numbers were shown to be low in patients with advanced disease and high in those with a more favourable prognosis. The B‐cell activation antigen CD 23 was similarly related to stage, being high in more favourable disease. Also, αIFNR expression was directly related to CD 23 positivity, but αIFN binding was not inhibited by CD 23 monoclonal antibody. There was no correlation between CD 19, 20, 22 and 24 antigen expression and either αIFNR numbers or clinical stage. Since CD23 antigen expression is a feature of B‐cell activation, we suggest that high CD23 and αIFNR positivity are manifestations of an activated cell phenotype and that cell activation in CLL is a feature of favourable disease.